key: cord-0855607-g70nvqsu authors: Kloc, Małgorzata; Ghobrial, Rafik M.; Kuchar, Ernest; Lewicki, Sławomir; Kubiak, Jacek Z. title: Development of child immunity in the context of COVID-19 pandemic date: 2020-06-13 journal: Clin Immunol DOI: 10.1016/j.clim.2020.108510 sha: ecd69c3028a1339db9e33edb045455777147a6d7 doc_id: 855607 cord_uid: g70nvqsu Children, because of having an immature immune system, are usually more prone than the adults to the microbial infections and have more severe symptoms, which is especially true for the newborns, and very young children. However, the review of clinical data from the current COVID-19 pandemic indicates otherwise. We discuss here what are the main features and components of children's immune system, the role of maternal transmission of immunity, and what are the possible explanations for the seemingly lower infection rate and severity of COVI-19 in children. During pregnancy, the developing fetus has to be tolerant of the maternal antigens, and the maternal immune system has to be fetotolerant. The reshaping of mother/fetus immune response, still not fully understood, relies on multiple mechanisms, including the emerging role of T regulatory cells (Tregs) in the achievement and maintenance of this tolerance (1) . After birth, the newborn becomes exposed to the enormous number of foreign antigens that require swift immune response. However, the immune system of the newborns is underdeveloped and subdued, fully maturing during the first 7-8 years of life. The first line immune responders present already in the fetus and newborn are the innate immune cells: monocytes, macrophages, dendritic cells, and neutrophils. The monocytes and macrophages in the newborn are immature and have lower cytokine response than in the adult. The mature neutrophils are already present at the 13 th week of pregnancy and increase in number during consecutive weeks. After birth, the number of neutrophils stabilizes but they have only weak bactericidal activity (2) . Interestingly, the newborns' plasmacytoid dendritic cells (pDC) show very low production of alpha and beta interferon in response to different viruses, such as respiratory syncytial virus, herpes simplex virus and cytomegalovirus (2, 3) . The NK cells of the fetus have low cytolytic activity, are hyperresponsive to the immunosuppressive activity of transforming growth factor-beta (TGF-β), and are hyporesponsive against cells lacking major histocompatibility complex (MHC) class I. At birth, the cytolytic activity of NK cells is only 50% of that in the adults, and they are hyporesponsive to IL-2 and IL-15 activation (2). Such a muted innate immune system in newborns results in a higher than in the adults, susceptibility to bacterial and viral infection. Studies are indicating that in older children the innate and adaptive immune system develops the immunological (trained) memory of hemopoietic progenitors and NK cells, after the repeated exposure to the antigens and vaccinations, which may give cross-protection against reinfections (4 -10). Besides the innate immunity, the fetus, newborn, and developing child also have adaptive immunity. One of the cellular components of adaptive immunity are the T cells. Although the CD4-and CD8-positive T cells are established around the 15 th week of pregnancy, and the mature T cells are already present in the newborn, they differ from the adult T cells by being more tolerogenic, and hyporesponsive to the antigens (2) . The newborns also have a special, recently discovered, a subpopulation of interleukin-8 (CXCL8)-producing T cells, which activate J o u r n a l P r e -p r o o f antimicrobial neutrophils (see above), and unconventional, γδT cells, which number decreases with age (2, 11, 12) . Other cells of the adaptive immunity are the B cells. In the newborn, and through the first few months of life, around 40% of the circulating B cells are the B1 cells that only produce low-affinity IgM, and later in life, they become replaced by the conventional B2 cells (2, 13) . Because the newborns and young children have an underdeveloped and immature immune system they have to, at least partially, rely on the immune factors supplied by the mother. They are also theories that the immune system of the fetus is trained by maternal inflammation, which influences, and establishes a long-lasting immunologic memory in the fetal hematopoietic stem cells (14) . Below we summarize the components and routs of maternally derived immunity. The placenta develops from the trophectoderm of the blastocyst and serves as a protective barrier, and promotes the growth of the fetus. During pregnancy the placenta reciprocally exchanges gases, nutrients, and waste products between the mother and fetus (15) . The placenta is also crucial for providing fetal and newborn immunity. Because the placenta is continuously exposed to the pathogens present in the mother's blood, it has several mechanisms protecting the fetus from the infection. The surface of the placenta is built of a continuous layer of cells without cell junctions, and the brush border of the placental surface has a network of very dense actin filaments. These two biophysical barriers prevent the entry of pathogens from the mothernal blood. In addition, the unique composition of the membrane of placental cells prevents the attachment and penetration of some of the pathogens (16, 17) . The placenta also secrets the antiviral compounds such as type III interferons, and, the enclosed within exosomes unique miRNAs, the trophomiRs, which prevent viral infection (18) (19) (20) . In humans, starting from the 16 th week of gestation, until birth, the placenta is also involved in the continuous transfer of passive immunity from the mother to the fetus. The surface cells of the placenta express neonatal receptors for immunoglobulin G (IgG), which bind and pass maternal antibodies to the fetus. In consequence, at birth, the fetus has more maternal IgGs than the mother (15, 17, 21) , which can protect infant during first months of life, until the maturation of their own immune system. Thus, the preterm infants, with a lower level of maternally derived antibodies, are more vulnerable to the infection. The vaginal delivery shapes, through the contact with mother's microorganisms, the composition of a child's gut microbiota, which, in turn, affects the development of the newborn's immune system (22) . The recent analysis, using the 16S rRNA gene amplicon sequencing and highresolution metagenomics of the microorganisms present in the neonatal gut after vaginal and caesarian section delivery, indicates that the vaginal birth enriches the gram-negative bacteria, including 23 enteric taxa of Bacteroidetes and Actinobacteria, in the newborns. This stimulates, via lipopolysaccharide (LPS) pathway, the production of pro-inflammatory cytokines TNF-a and IL-18, increases the immunostimulatory potentials of the gut microbiome, and primes immune system of neonates born by vaginal delivery (22) . Breast milk contains not only the basic nutrients (proteins, carbohydrates, and fats) but also a multitude of factors that drive development and maturation of the immune system and protect newborns from the environmental pathogens. Milk contains not only antibacterial compounds, chemokines, cytokines, immunoglobulins, hormones, and growth factors (23) but also the immune cells including lymphocytes, neutrophils, and macrophages. The composition and the level of these compounds change during the different phases of lactation in response to the changing needs of the growing and developing infant. Recent studies of the milk proteome (24) showed that between the first 72 hours and 3 days postpartum the colostrum milk has the highest level of the immunoregulatory factors. The transitional milk produced between the 3 rd and 15 th day is very rich in proteins, and the mature, produced from day 16 th , milk is enriched in fatty acids, and its overall composition becomes less variable. The antimicrobial compounds in the milk include among others: lactoferrin, haptocorrin, lysozyme, defensins, cathelicidins, proteins of the complement system, components of the lactoperoxidase system (LP-s), and various glycans. The lactoferrin and haptocorrin are bacteriostatic through the binding of free ions, and vitamin B 12 , respectively, which are required for bacterial growth (25) . The lysozyme, defensins, and cathelicidins disrupt or puncture the wall of the bacteria, leading to their lysis (26) . The proteins of the complement system opsonize pathogen to promote phagocytosis, act as the chemoattractants recruiting and activating phagocytes, and /or puncture bacterial membrane (27) . The lactoperoxidase catalyzes (from the thiocyanate ions in the J o u r n a l P r e -p r o o f Journal Pre-proof presence of hydrogen peroxide) production of the antibacterial substance, and glycans reduce proliferation and virulence of some pathogens (28) . Human early colostrum milk contains around 5 million leukocytes/ml. Among them, 10% are B cells, T cells, and NK cells. The remaining leukocytes are mainly neutrophils and macrophages. The number of leukocytes decreases with time, and mature milk has approximately 10 times fewer leukocytes than the colostrum (29, 30) . The breast milk also contains a high number of recently discovered innate lymphoid cells (ILCs), which had been divided into 3 subgroups: ILC1s, ILC2s, and ILC3s, with different cytokine and gene expression profiles (31, 32) . The ILCs do not have receptors for the antigens but, instead, rapidly respond to infection and produce the same array of inflammatory mediators like the T cells (32) . The immune cells present in breast milk are resistant to the child digestive enzymes and can mount a vigorous immune response by directly destroying pathogens they encounter and shape the infant's gut microbiota, and immunity (29-33). Over the years, the research and clinical data have shown that because children have an immature immune system, they are more prone than the adults to microbial infections, and have higher severity of symptoms, which is especially true for the newborns and very young children. The analyses of clinical data from the current COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are conflicting in this respect. Some data indicate that children are rarely infected and have less severe symptoms, and other show otherwise (4). Analysis of clinical data of 2135, 2-13 years old children in China, between January 16, 2020, and February 8, 2020, showed that more than 90% of children were either asymptomatic or had less severe symptoms than the adults and that children are no less susceptible than adults to SARS-CoV-2 infection, and the infants are more vulnerable (10.6%) to the infection than older children (34) . Some studies showed that the frequency and what would be a plausible explanation for this phenomenon? One explanation is that the child's immune system has been trained by the maternal respiratory inflammations to develop a longlasting immunologic memory against respiratory viruses (4, 14) . Also, frequent exposure of children to respiratory viruses in daycare, kindergarten, and school may lead to the development of partial protection against the SARS-CoV-2 virus. Another explanation may lie in the difference between children and adults in the expression level of the SARS-CoV-2 receptor. The entry of the SARS-CoV-2 to the host cells relies on the angiotensin-converting enzyme 2 (ACE2) receptors present in various tissues, and also in lung epithelial cells, and alveolar macrophages (36, 37) . Recently, Bunyavanich et al. (38) showed that in the cohort of 305 individuals (4 to 60 years old) the expression of ACE2 in the nasal epithelium, which serves as a virus' point of entry, increased with age: ACE2 expression was lowest in younger children (below 10 years old), and successively higher in older children ( Maternal Acceptance of the Fetus: True Human Tolerance Evolution of the immune system in humans from infancy to old age Preterm neonates display altered plasmacytoid dendritic cell function and morphology Will children reveal their secret? The coronavirus dilemma Immunomodulating effect of influenza vaccination in the elderly differing in health status SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics Modulation of Myelopoiesis progenitors is an integral component of trained immunity The role of virus infection in deregulating the cytokine response to secondary bacterial infection Epigenetic control of innate and adaptive immune memory Neonates harbour highly active gamma delta T cells with selective impairments in preterm infants Gamma delta T-cell conference 2012: close encounters for the fifth time Developmental and maturational changes in human blood lymphocyte subpopulations Training the Fetal Immune System Through Maternal Inflammation-A Layered Hygiene Hypothesis. Front Immunol. 11: 123 Placenta: The Forgotten Organ Human Placental Syncytiotrophoblasts Restrict Toxoplasma gondii Attachment and Replication and Respond to Infection by Producing Immunomodulatory Chemokines Immune responses at the maternal-fetal interface Human trophoblasts confer resistance to viruses implicated in perinatal infection Type III Interferons Produced by Human Placental Trophoblasts Confer Protection Against Zika Virus Infection The Function of TrophomiRs and Other MicroRNAs in the Human Placenta Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies Birth mode is associated with earliest strain-conferred gut microbiome functions and immunostimulatory potential Human Milk Composition: Nutrients and Bioactive Factors The Functional Power of the Human Milk Proteome Human Milk Proteins: Key Components for the Biological Activity of Human Milk Bioactive Proteins in Breast Milk Complement-mediated Bactericidal Activity of Human Milk to a Serum-Susceptible Strain of E. Coli 0111 An Important Milk Enzyme: Lactoperoxidase. Milk Proteins -From Structure to Biological Properties and Health Aspects Breastfeeding, the Immune Response, and Long-term Health Immunology of breast milk Presence and Profile of Innate Lymphoid Cells in Human Breast Milk Innate lymphoid cells: A new paradigm in immunology Mother's Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity. Front Immunol Epidemiology of COVID-19 Among Children in China The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China Novel Coronavirus Pneumonia Emergency Response Epidemiology Team 41: 145 Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 The pivotal link between ACE2 deficiency and SARS-CoV-2 infection Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults Individual Variation of the SARS-CoV2 Receptor ACE2 Gene Expression and Regulation Cytokine Storm in COVID-19 and Treatment Anakinra in COVID-19: important considerations for clinical trials We acknowledge the funding from the Polish Ministry of National Defense "Kościuszko" # 5508/2017/DA grant to JZK.